$5.25 Earnings Per Share Expected for UnitedHealth Group Incorporated (NYSE:UNH) This Quarter

Wall Street brokerages expect UnitedHealth Group Incorporated (NYSE:UNHGet Rating) to post earnings of $5.25 per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have made estimates for UnitedHealth Group’s earnings, with the lowest EPS estimate coming in at $5.10 and the highest estimate coming in at $5.44. UnitedHealth Group reported earnings of $4.70 per share in the same quarter last year, which would indicate a positive year-over-year growth rate of 11.7%. The firm is scheduled to report its next earnings results before the market opens on Monday, January 1st.

According to Zacks, analysts expect that UnitedHealth Group will report full year earnings of $21.76 per share for the current year, with EPS estimates ranging from $21.55 to $22.37. For the next financial year, analysts anticipate that the business will report earnings of $24.90 per share, with EPS estimates ranging from $24.34 to $25.65. Zacks’ earnings per share calculations are an average based on a survey of analysts that cover UnitedHealth Group.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The business had revenue of $80.15 billion for the quarter, compared to analyst estimates of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The company’s revenue was up 14.2% on a year-over-year basis. During the same period last year, the business earned $5.31 EPS.

UNH has been the subject of several recent analyst reports. Morgan Stanley boosted their target price on UnitedHealth Group from $570.00 to $577.00 and gave the stock an “overweight” rating in a research note on Monday, April 18th. Wells Fargo & Company upped their target price on shares of UnitedHealth Group from $565.00 to $613.00 and gave the company an “overweight” rating in a report on Friday, April 22nd. SVB Leerink boosted their price target on shares of UnitedHealth Group from $550.00 to $600.00 and gave the company an “outperform” rating in a research report on Tuesday, April 19th. Cowen lifted their target price on UnitedHealth Group from $512.00 to $596.00 in a research report on Monday, April 18th. Finally, Truist Financial upped their target price on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Two investment analysts have rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $550.17.

NYSE:UNH opened at $492.08 on Tuesday. UnitedHealth Group has a 1 year low of $383.12 and a 1 year high of $553.29. The stock has a market cap of $461.66 billion, a P/E ratio of 26.93, a P/E/G ratio of 1.49 and a beta of 0.83. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.78 and a current ratio of 0.78. The stock has a 50-day simple moving average of $510.92 and a 200-day simple moving average of $486.10.

In other news, Director Richard T. Burke sold 6,000 shares of the stock in a transaction dated Friday, February 25th. The shares were sold at an average price of $470.38, for a total value of $2,822,280.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Richard T. Burke sold 3,000 shares of the business’s stock in a transaction dated Thursday, March 24th. The stock was sold at an average price of $508.80, for a total transaction of $1,526,400.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 18,000 shares of company stock valued at $8,823,765. Company insiders own 0.55% of the company’s stock.

A number of institutional investors have recently bought and sold shares of UNH. EP Wealth Advisors LLC raised its position in UnitedHealth Group by 49,050.0% during the third quarter. EP Wealth Advisors LLC now owns 15,517,624 shares of the healthcare conglomerate’s stock worth $11,590,000 after acquiring an additional 15,486,052 shares during the last quarter. Norges Bank purchased a new stake in UnitedHealth Group in the 4th quarter valued at approximately $4,478,185,000. Arrowstreet Capital Limited Partnership increased its position in UnitedHealth Group by 1,682.4% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,691,542 shares of the healthcare conglomerate’s stock worth $1,372,606,000 after buying an additional 2,540,538 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of UnitedHealth Group by 60.4% in the first quarter. The Manufacturers Life Insurance Company now owns 5,009,284 shares of the healthcare conglomerate’s stock valued at $2,580,442,000 after acquiring an additional 1,886,128 shares in the last quarter. Finally, Capital Research Global Investors boosted its stake in shares of UnitedHealth Group by 8.3% during the first quarter. Capital Research Global Investors now owns 19,273,691 shares of the healthcare conglomerate’s stock valued at $9,829,129,000 after acquiring an additional 1,482,338 shares during the last quarter. 87.48% of the stock is currently owned by institutional investors.

About UnitedHealth Group (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Recommended Stories

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.